Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.

Zhou, Liying; Li, Qing; Xu, Jingshen; Wang, Shuaikang; Song, Zhiqiang; Chen, Xinyi; Ma, Yan; Lin, Zhiguang; Chen, Bobin; Huang, He

Zhou, Liying; Li, Qing; Xu, Jingshen; Wang, Shuaikang; Song, Zhiqiang; Chen, Xinyi; Ma, Yan; Lin, Zhiguang; Chen, Bobin; Huang, He.

Afiliação

Zhou L; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, 200438, China.
Li Q; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200438, China.
Xu J; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, 200438, China.
Wang S; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, 200438, China.
Song Z; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, 200438, China.
Chen X; School of Life Sciences, Inner Mongolia University, Hohhot Inner Mongolia, 010021, China.
Ma Y; Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, 200438, China.
Lin Z; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200438, China.
Chen B; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200438, China.
Huang H; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, 200438, China.

Neurooncol Adv ; 5(1): vdac181, 2023.

Article em En | MEDLINE | ID: mdl-36879663

Palavras-chave

high-dose methotrexate; metabolomics; prediction model; primary CNS lymphoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google